Griscelli syndrome is a rare autosomal recessive disorder. It is characterized by pigment dilution and variable immune deficiency leading to increased susceptibility to certain infections and a tendency to develop a life-threatening hemophagocytic syndrome known as the accelerated phase. Griscelli syndrome is now classified into 3 types based on the genetic and molecular features. Primary neurological presentation without the accelerated phase is rare in type 2. In this article, the authors report a boy who was presented with seizures and diffuse white matter involvement unaccompanied by the other features of the accelerated phase. Mutation analysis in family members revealed the presence of a missense mutation in Rab27a gene. In addition to the rare presentation, this is the first case of Griscelli syndrome to be reported from Jordan.
Griscelli C. , Durandy A., Guy-Grand D., et al. A syndrome associating partial albinism and immunodeficiency. Am J Med. 1978;65:691-702.
2.
Klein C., Philippe N., Le Deist F., et al. Partial albinism with immunodeficiency (Griscelli syndrome) . J Pediatr. 1994;125:886-895.
3.
Sanal O., Yel L., Kucukali T., et al. An allelic variant of Griscelli disease: presentation with severe hypotonia, mental-motor retardation, and hypopigmentation consistent with Elejalde syndrome (neuroectodermal melanolysosomal disorder). J Neurol. 2000;247: 570-572.
4.
Pastural E., Barrat FJ, Dufourcq-Lagelouse R., et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin Va gene. Nat Genet. 1997;16:289-292.
5.
Menasche G., Ho CH, Sanal O., et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). [Erratum: J Clin Invest. 2005;115:1100]. J Clin Invest. 2003;112:450-456.
6.
Menasche G., Feldmann J., Houdusse A., et al. Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients. Blood. 2003;101:2736-2742.
7.
Barral DC, Ramalho JS, Anders R., et al. Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome. J Clin Invest. 2002 ;110:247-257.
8.
Anikster Y., Huizing M., Anderson PD, et al. Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB 27A, not MYO5A. Am J Hum Genet . 2002;71:407-414.
9.
Rajadhyax M. , Neti G., Crow Y., Tyagi A.Neurological presentation of Griscelli syndrome: obstructive hydrocephalus without haematological abnormalities or organomegaly . Brain Dev. 2007;29:247-250.
10.
Aksu G., Kutukculer N., Genel F., et al. Griscelli syndrome without hemophagocytosis in an eleven year old girl, expanding the phenotypic spectrum of RAB 27A mutation in humans . Am J Med Genet A. 2003;116:329-333.
11.
Brismar J., Harfi H.Partial albinism with immunodeficiency-a rare syndrome with prominent posterior fossa white matter changes. AJNR Am J Neuroradiol. 1992;13:387-393.
12.
Duran-McKinster C., Rodriguez-Jurado R., Ridaura C., et al. Elejalde syndrome-a melanolysosomal neurocutaneous syndrome: clinical and morphological findings in 7 patients. Arch Dermatol. 1999 ;135:182-186.
13.
Hurvitz H., Gillis R., Klaus S.A kindred with Griscelli disease: spectrum of neurological involvement. Eur J Pediatr. 1993;152: 402-405.
14.
Sarper N., Akansel G., Aydoan M., et al. Neuroimaging abnormalities in Griscelli's disease. Pediatr Radiol. 2002;32:875-878.
15.
Sanal O., Ersoy F., Tezcan I., et al. Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity. Clin Immunol. 2002 ;22:237-243.
16.
Tardieu M., Lacroix C., Neven B., et al. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood. 2005;106:40-42.
17.
Hauser RA, Friedlander J., Baker MJ, et al. Adult Chediak-Higashi parkinsonian syndrome with dystonia. Mov Disord. 2000;15:705-708.
18.
Ballard R., Tien RD, Nohria V., Juel V.The Chédiak-Higashi syndrome: CT and MR findings. Pediatr Radiol. 1994;24:266-267.
19.
Ashrafi MR, Mohseni M., Yazdani S., et al. Bilateral basal ganglia involvement in a patient with Griscelli syndrome. Eur J Paediatr Neurol. 2006;10:207-209.
20.
Schneider LC , Berman RS, Shea CR, et al. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome). J Clin Immunol. 1990;10:146-153.
21.
Tezcan I., Sanal O., Ersoy F., et al. Successful bone marrow transplantation in a case with Griscelli disease who presented in accelerated phase with neurological involvement. Bone Marrow Transplant. 1999;24:931-933.
22.
Janka GEFamilial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166:95-109.
